Antonella Gozzini
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments 33
- Acute Myeloid Leukemia Research 26
- Multiple Myeloma Research and Treatments 8
- Hematopoietic Stem Cell Transplantation 6
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 23
- Rheumatology top 5%
- Eosinophilic Disorders and Syndromes 12
- Oncology top 10%
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research 12
- Protein Degradation and Inhibitors 6
- Co-authors
- Valeria SantiniGermano FerrariPersio Dello SbarbaElisabetta RovidaAlberto BosiPierfrancesco TassoneNikhil C. MunshiSalvatore Venuta
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Antonella Gozzini
70 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 92
- Hematology 1.0k
- Genetics 533
- Rheumatology 234
- Oncology 408
- Molecular Biology 752
Countries citing papers authored by Antonella Gozzini
This map shows the geographic impact of Antonella Gozzini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonella Gozzini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonella Gozzini more than expected).
Fields of papers citing papers by Antonella Gozzini
This network shows the impact of papers produced by Antonella Gozzini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonella Gozzini. The network helps show where Antonella Gozzini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Antonella Gozzini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2021 | 1 | |
| 3 | 2021 | 15 | |
| 4 | 2018 | 20 | |
| 5 | 2017 | 69 | |
| 6 | ATHEROTHROMBOTIC RISK ASSESSMENT DURING TYROSINE KINASE INHIBITORS TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS: NEW INSIGHT? | 2014 | 1 |
| 7 | 2013 | 70 | |
| 8 | 2013 | 5 | |
| 9 | 2012 | 25 | |
| 10 | 2012 | 10 | |
| 11 | 2012 | 17 | |
| 12 | 2012 | 39 | |
| 13 | 2011 | 12 | |
| 14 | A european observational study of dasatinib in the management of imatinib-resistant and -intolerant patients with chronic myeloid leukemia: forte study (ca180-211) | 2010 | 1 |
| 15 | 2010 | 9 | |
| 16 | 2010 | 75 | |
| 17 | 2008 | 3 | |
| 18 | 2007 | 37 | |
| 19 | 2006 | 7 | |
| 20 | 2005 | 20 |
About Antonella Gozzini
Antonella Gozzini is a scholar working on Hematology, Genetics and Rheumatology, having authored 75 papers that have together received 1.7k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (33 papers), Acute Myeloid Leukemia Research (26 papers), Chronic Lymphocytic Leukemia Research (23 papers), Histone Deacetylase Inhibitors Research (12 papers), Eosinophilic Disorders and Syndromes (12 papers), Multiple Myeloma Research and Treatments (8 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Hematology (1.0k citations), Genetics (533 citations) and Rheumatology (234 citations). Antonella Gozzini has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Valeria Santini, Germano Ferrari, Persio Dello Sbarba, Elisabetta Rovida, Alberto Bosi, Pierfrancesco Tassone, Nikhil C. Munshi, Salvatore Venuta, Kenneth C. Anderson and Masood A. Shammas. Their work appears in journals such as Blood, Neurology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.